Eupraxia Pharmaceuticals Inc

Small-Cap Stocks Stocks Under $10 Biotech Stocks Healthcare Stocks

$7.89

+0.09 (+1.15%)

As of May 9, 1:45 AM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 10 91%

Hold 1 9%

Sell 0 0%

Price Target

Analyst Price Target +462.0% upside

Low Target $25.23

Average Target $44.34

High Target $48.95

Current Price $7.89

Current
$7.89

Target
$44.34

$25.23 $44.34 avg $48.95

Scenario Analysis

Bear Case

$25.23

219.8%

Low target

Base Case

$44.34

+462.0%

Avg target

Bull Case

$48.95

+520.4%

High target

Risk/Reward

2.4x

Favorable

Price in Context

52-Week High

$12.86

-38.6% from high

52-Week Low

$5.01

+57.5% from low

Target vs 52W High

$44.34

+244.8% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	75%	$257.58	+27.8%
AMGN Amgen Inc	Hold	44	48%	$190.87	-42.5%
GILD Gilead Sciences Inc	Strong Buy	39	79%	$362.68	+176.2%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	+2.0%
REGN Regeneron Pharmaceuticals	Strong Buy	38	79%	$76.80	-89.3%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-65.3%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-19.5%
INSM Insmed Inc	Strong Buy	28	96%	$143.40	+41.5%